Global Propofol Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Propofol Market Research Report 2024
The Propofol API is an intravenous, short acting anesthetic with rapid onset of action used in the induction and maintenance of anesthesia.
According to Mr Accuracy reports’s new survey, global Propofol market is projected to reach US$ 22 million in 2034, increasing from US$ 18 million in 2024, with the CAGR of 3.6% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Propofol market research.
Bachem is the world's largest manufacturers of Propofol, with a market share of nearly 50%, other major manufacturers include Curia and SI Group. Europe dominates the global propofol market with market share 60% in production, followed by China and India. In terms of product types, propofol with purity below 99.5% occupied more than 99% of the share, and the rest is propofol with purity over 99.5%. In terms of product application, propofol injection emulsion occupies for a share of 65%, and propofol mct/lct injection occupies for a share of 35%.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Propofol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Bachem
Curia
SI Group
Neuland Laboratories
Harman Finochem
Midas Pharma
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Segment by Type
Purity above 99.5%
Purity below 99.5%
Propofol Injectable Emulsion
Propofol MCT/LCT Injectable Emulsion
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Propofol report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Propofol market is projected to reach US$ 22 million in 2034, increasing from US$ 18 million in 2024, with the CAGR of 3.6% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Propofol market research.
Bachem is the world's largest manufacturers of Propofol, with a market share of nearly 50%, other major manufacturers include Curia and SI Group. Europe dominates the global propofol market with market share 60% in production, followed by China and India. In terms of product types, propofol with purity below 99.5% occupied more than 99% of the share, and the rest is propofol with purity over 99.5%. In terms of product application, propofol injection emulsion occupies for a share of 65%, and propofol mct/lct injection occupies for a share of 35%.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Propofol market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Bachem
Curia
SI Group
Neuland Laboratories
Harman Finochem
Midas Pharma
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Segment by Type
Purity above 99.5%
Purity below 99.5%
Segment by Application
Propofol Injectable Emulsion
Propofol MCT/LCT Injectable Emulsion
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Propofol report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source